Literature DB >> 30089629

Making HSCs in vitro: don't forget the hemogenic endothelium.

Bradley W Blaser1, Leonard I Zon2.   

Abstract

Generating a hematopoietic stem cell (HSC) in vitro from nonhematopoietic tissue has been a goal of experimental hematologists for decades. Until recently, no in vitro-derived cell has closely demonstrated the full lineage potential and self-renewal capacity of a true HSC. Studies revealing stem cell ontogeny from embryonic mesoderm to hemogenic endothelium to HSC provided the key to inducing HSC-like cells in vitro from a variety of cell types. Here we review the path to this discovery and discuss the future of autologous transplantation with in vitro-derived HSCs as a therapeutic modality.
© 2018 by The American Society of Hematology.

Mesh:

Year:  2018        PMID: 30089629      PMCID: PMC6161767          DOI: 10.1182/blood-2018-04-784140

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  92 in total

1.  Functional characterization of B lymphocytes generated in vitro from embryonic stem cells.

Authors:  S K Cho; T D Webber; J R Carlyle; T Nakano; S M Lewis; J C Zúñiga-Pflücker
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  Definitive hematopoiesis is autonomously initiated by the AGM region.

Authors:  A Medvinsky; E Dzierzak
Journal:  Cell       Date:  1996-09-20       Impact factor: 41.582

3.  Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment.

Authors:  Faiyaz Notta; Sergei Doulatov; Elisa Laurenti; Armando Poeppl; Igor Jurisica; John E Dick
Journal:  Science       Date:  2011-07-08       Impact factor: 47.728

4.  Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells.

Authors:  Anthony E Boitano; Jian Wang; Russell Romeo; Laure C Bouchez; Albert E Parker; Sue E Sutton; John R Walker; Colin A Flaveny; Gary H Perdew; Michael S Denison; Peter G Schultz; Michael P Cooke
Journal:  Science       Date:  2010-08-05       Impact factor: 47.728

Review 5.  Inherited bone marrow failure syndromes: considerations pre- and posttransplant.

Authors:  Blanche P Alter
Journal:  Blood       Date:  2017-11-23       Impact factor: 22.113

6.  Induced pluripotent stem cells generated without viral integration.

Authors:  Matthias Stadtfeld; Masaki Nagaya; Jochen Utikal; Gordon Weir; Konrad Hochedlinger
Journal:  Science       Date:  2008-09-25       Impact factor: 47.728

7.  Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors.

Authors:  César Cobaleda; Wolfram Jochum; Meinrad Busslinger
Journal:  Nature       Date:  2007-09-12       Impact factor: 49.962

8.  NOTCH signaling specifies arterial-type definitive hemogenic endothelium from human pluripotent stem cells.

Authors:  Gene I Uenishi; Ho Sun Jung; Akhilesh Kumar; Mi Ae Park; Brandon K Hadland; Ethan McLeod; Matthew Raymond; Oleg Moskvin; Catherine E Zimmerman; Derek J Theisen; Scott Swanson; Owen J Tamplin; Leonard I Zon; James A Thomson; Irwin D Bernstein; Igor I Slukvin
Journal:  Nat Commun       Date:  2018-05-08       Impact factor: 14.919

9.  A network of epigenetic regulators guides developmental haematopoiesis in vivo.

Authors:  Hsuan-Ting Huang; Katie L Kathrein; Abby Barton; Zachary Gitlin; Yue-Hua Huang; Thomas P Ward; Oliver Hofmann; Anthony Dibiase; Anhua Song; Svitlana Tyekucheva; Winston Hide; Yi Zhou; Leonard I Zon
Journal:  Nat Cell Biol       Date:  2013-11-17       Impact factor: 28.824

10.  Haematopoietic stem and progenitor cells from human pluripotent stem cells.

Authors:  Ryohichi Sugimura; Deepak Kumar Jha; Areum Han; Clara Soria-Valles; Edroaldo Lummertz da Rocha; Yi-Fen Lu; Jeremy A Goettel; Erik Serrao; R Grant Rowe; Mohan Malleshaiah; Irene Wong; Patricia Sousa; Ted N Zhu; Andrea Ditadi; Gordon Keller; Alan N Engelman; Scott B Snapper; Sergei Doulatov; George Q Daley
Journal:  Nature       Date:  2017-05-17       Impact factor: 49.962

View more
  7 in total

1.  Single-cell transcriptome analysis of embryonic and adult endothelial cells allows to rank the hemogenic potential of post-natal endothelium.

Authors:  Artem Adamov; Yasmin Natalia Serina Secanechia; Christophe Lancrin
Journal:  Sci Rep       Date:  2022-07-16       Impact factor: 4.996

2.  Notch signaling mitigates chemotherapy toxicity by accelerating hematopoietic stem cells proliferation via c-Myc.

Authors:  Juanjuan Chen; Yan Dong; Jie Peng; Jian Zhang; Xiaotong Gao; Aili Lu; Chunlin Shen
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

3.  In vivo generation of haematopoietic stem/progenitor cells from bone marrow-derived haemogenic endothelium.

Authors:  Rodolphe Gautier; Laurence Petit; Laurent Yvernogeau; Hanane Khoury; Frédéric Relaix; Vanessa Ribes; Helen Sang; Pierre Charbord; Michèle Souyri; Catherine Robin; Thierry Jaffredo
Journal:  Nat Cell Biol       Date:  2019-11-04       Impact factor: 28.824

Review 4.  Endothelial-to-haematopoietic transition: an update on the process of making blood.

Authors:  Katrin Ottersbach
Journal:  Biochem Soc Trans       Date:  2019-03-22       Impact factor: 5.407

Review 5.  Hematopoietic stem cells from pluripotent stem cells: Clinical potential, challenges, and future perspectives.

Authors:  Selami Demirci; Alexis Leonard; John F Tisdale
Journal:  Stem Cells Transl Med       Date:  2020-07-29       Impact factor: 6.940

6.  Generation of Hematopoietic-Like Stem Cells from Adult Human Peripheral Blood Following Treatment with Platelet-Derived Mitochondria.

Authors:  Haibo Yu; Wei Hu; Xiang Song; Dante Descalzi-Montoya; Zheng Yang; Robert Korngold; Yong Zhao
Journal:  Int J Mol Sci       Date:  2020-06-15       Impact factor: 5.923

7.  Inducible Forward Programming of Human Pluripotent Stem Cells to Hemato-endothelial Progenitor Cells with Hematopoietic Progenitor Potential.

Authors:  Lucas Lange; Dirk Hoffmann; Adrian Schwarzer; Teng-Cheong Ha; Friederike Philipp; Daniela Lenz; Michael Morgan; Axel Schambach
Journal:  Stem Cell Reports       Date:  2019-12-12       Impact factor: 7.765

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.